• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病患者中作为心房颤动危险因素的临床和超声心动图参数

Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy.

作者信息

Klopotowski Mariusz, Kwapiszewska Aleksandra, Kukula Krzysztof, Jamiolkowski Jacek, Dabrowski Maciej, Derejko Pawel, Oreziak Artur, Baranowski Rafal, Spiewak Mateusz, Marczak Magdalena, Klisiewicz Anna, Szepietowska Barbara, Chmielak Zbigniew, Witkowski Adam

机构信息

Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.

Department of Population Medicine and Civilization Diseases Prevention, Medical University of Bialystok, Bialystok, Poland.

出版信息

Clin Cardiol. 2018 Oct;41(10):1336-1340. doi: 10.1002/clc.23050. Epub 2018 Oct 16.

DOI:10.1002/clc.23050
PMID:30120784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6490001/
Abstract

BACKGROUND

Atrial fibrillation (AF) is a common complication in patients with hypertrophic cardiomyopathy (HCM) and may contribute to high cardiovascular morbidity and mortality. Therefore, it is important to assess parameters associated with AF in HCM patients.

HYPOTHESIS

The aim of the study was to evaluate AF prevalence in patients with HCM and to investigate risk factors for AF.

METHODS

Five hundred and forty-six HCM patients aged below 65 were included into analysis. Clinical and echocardiographic parameters were analyzed.

RESULTS

In 141 patients (25.8%) AF episodes were recorded. The following factors were identified as risk factors for AF in patients with HCM: age ≥ 45 years (OR 2.38, CI 1.40-4.05, P = 0.001), past history of presyncope or syncope (OR 2.25, CI 1.35-3.74, P = 0.002), non-sustained ventricular tachycardia (nsVT) (OR 2.70, CI 1.60-4.57, P < 0.001), left atrium diameter during first assessment (OR 1.065, CI 1.03-1.11, P = 0.001), left atrium diameter at the last assessment before AF occurrence (OR 1.10, CI 1.06-1.14, P < 0.001) and left ventricular ejection fraction at the last assessment before AF occurrence (CI 0.96, CI 0.94-0.98, P = 0.001).

CONCLUSIONS

We confirm that AF is a common complication for patients with HCM. Identification of patients with high risk for AF and implementation of preventive strategies may reduce AF occurrence and its complications.

摘要

背景

心房颤动(AF)是肥厚型心肌病(HCM)患者的常见并发症,可能导致较高的心血管发病率和死亡率。因此,评估HCM患者中与AF相关的参数很重要。

假设

本研究的目的是评估HCM患者的AF患病率,并调查AF的危险因素。

方法

纳入546例年龄在65岁以下的HCM患者进行分析。分析临床和超声心动图参数。

结果

141例患者(25.8%)记录到AF发作。以下因素被确定为HCM患者AF的危险因素:年龄≥45岁(OR 2.38,CI 1.40 - 4.05,P = 0.001)、既往有先兆晕厥或晕厥史(OR 2.25,CI 1.35 - 3.74,P = 0.002)、非持续性室性心动过速(nsVT)(OR 2.70,CI 1.60 - 4.57,P < 0.001)、首次评估时的左心房直径(OR 1.065,CI 1.03 - 1.11,P = 0.001)、AF发生前最后一次评估时的左心房直径(OR 1.10,CI 1.06 - 1.14,P < 0.001)以及AF发生前最后一次评估时的左心室射血分数(CI 0.96,CI 0.94 - 0.98,P = 0.001)。

结论

我们证实AF是HCM患者的常见并发症。识别AF高危患者并实施预防策略可能会减少AF的发生及其并发症。

相似文献

1
Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者中作为心房颤动危险因素的临床和超声心动图参数
Clin Cardiol. 2018 Oct;41(10):1336-1340. doi: 10.1002/clc.23050. Epub 2018 Oct 16.
2
E/e' ratio and left atrial area are predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy.E/e' 比值和左心房面积是肥厚型心肌病患者发生心房颤动的预测指标。
Echocardiography. 2018 Jul;35(7):935-940. doi: 10.1111/echo.13857. Epub 2018 Mar 5.
3
Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality.肥厚型心肌病中的心房颤动:发病率和死亡率增加的转折点。
Hellenic J Cardiol. 2017 Sep-Oct;58(5):331-339. doi: 10.1016/j.hjc.2017.01.027. Epub 2017 Feb 20.
4
Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.肥厚型心肌病中心房颤动未来发作的预测因素。
Arch Cardiovasc Dis. 2018 Oct;111(10):591-600. doi: 10.1016/j.acvd.2018.03.007. Epub 2018 Jun 6.
5
Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation.肥厚型心肌病合并心房颤动患者的左心室重构
BMC Cardiovasc Disord. 2018 Nov 3;18(1):207. doi: 10.1186/s12872-018-0945-7.
6
Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.斑点追踪超声心动图测量肥厚型心肌病患者左心房主动功能的增量价值
Echocardiography. 2018 Aug;35(8):1138-1148. doi: 10.1111/echo.13886. Epub 2018 Apr 12.
7
Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy.比较伴有和不伴有肥厚的心房颤动及肥厚型心肌病患者的左心房重构特点。
Sci Rep. 2021 Jun 14;11(1):12411. doi: 10.1038/s41598-021-91892-y.
8
Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy.心房颤动对心尖肥厚型心肌病临床病程的影响。
Heart. 2017 Oct;103(19):1496-1501. doi: 10.1136/heartjnl-2016-310720. Epub 2017 Apr 20.
9
Predictors of atrial fibrillation in hypertrophic cardiomyopathy.肥厚型心肌病中心房颤动的预测因素
Heart. 2017 May;103(9):672-678. doi: 10.1136/heartjnl-2016-309672. Epub 2016 Oct 28.
10
Right Ventricular and Right Atrial Involvement Can Predict Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy?肥厚型心肌病患者右心室和右心房受累能否预测心房颤动?
Int J Med Sci. 2016 Jan 1;13(1):1-7. doi: 10.7150/ijms.13530. eCollection 2016.

引用本文的文献

1
Clinical and Echocardiographic Particularities of Hypertrophic Cardiomyopathy in a Brazilian Population and its Prognostic Impact.巴西人群肥厚型心肌病的临床和超声心动图特征及其预后影响。
Arq Bras Cardiol. 2025 Apr;122(4):e20240640. doi: 10.36660/abc.20240640.
2
Predicting New-Onset Atrial Fibrillation in Hypertrophic Cardiomyopathy: A Review.肥厚型心肌病新发心房颤动的预测:综述
J Clin Med. 2025 Mar 16;14(6):2018. doi: 10.3390/jcm14062018.
3
Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.《2024年墨西哥肥厚型心肌病诊断与治疗指南》
Arch Cardiol Mex. 2024;94(Supl 4):1-75. doi: 10.24875/ACM.M25000098.
4
Postoperative Atrial Fibrillation Prediction by Left Atrial Size in Coronary Artery Bypass Grafting and Five-Year Survival Outcome.冠状动脉搭桥术中左心房大小对术后房颤的预测及五年生存结局
J Clin Med. 2024 Jun 26;13(13):3738. doi: 10.3390/jcm13133738.
5
Evaluating the consistency in different methods for measuring left atrium diameters.评价不同方法测量左心房直径的一致性。
BMC Med Imaging. 2024 Mar 5;24(1):57. doi: 10.1186/s12880-024-01231-6.
6
Left Atrial Size; a Missing Component in Scoring Systems for Predicting Atrial Fibrillation Following Coronary Artery Bypass Surgery.左心房大小:冠状动脉搭桥术后预测心房颤动评分系统中缺失的组成部分。
Acta Cardiol Sin. 2020 Sep;36(5):456-463. doi: 10.6515/ACS.202009_36(5).20181023A.

本文引用的文献

1
Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy.肥厚型心肌病中诱发的左心室流出道峰值梯度对临床结局的影响。
Int J Cardiol. 2017 Sep 15;243:290-295. doi: 10.1016/j.ijcard.2017.04.039.
2
ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.肥厚型心肌病的ESC猝死风险模型:定量对比增强CMR在中危患者中的增量价值。
Clin Cardiol. 2017 Oct;40(10):853-860. doi: 10.1002/clc.22735. Epub 2017 Jun 14.
3
Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy.肥厚型心肌病患者临床无症状性房颤发作的发生率及自然病史
Am J Cardiol. 2017 Jun 1;119(11):1862-1865. doi: 10.1016/j.amjcard.2017.02.040. Epub 2017 Mar 16.
4
Incidence of Atrial Fibrillation following Alcohol Septal Ablation for Hypertrophic Cardiomyopathy.肥厚型心肌病酒精室间隔消融术后房颤的发生率
Ann Noninvasive Electrocardiol. 2016 Sep;21(5):443-9. doi: 10.1111/anec.12335. Epub 2016 Mar 11.
5
The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.心脏磁共振成像在肥厚型心肌病患者心源性猝死风险分层中的价值及延迟钆增强分布情况
J Cardiol. 2016 Jul;68(1):49-56. doi: 10.1016/j.jjcc.2015.07.020. Epub 2015 Sep 9.
6
Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population.肥厚型心肌病中的心房颤动:大型高危人群中的患病率、临床相关性及死亡率
J Am Heart Assoc. 2014 Jun 25;3(3):e001002. doi: 10.1161/JAHA.114.001002.
7
Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance.肥厚型心肌病中心房重构和心血管磁共振识别的心房颤动易患标志物。
Am J Cardiol. 2014 Apr 15;113(8):1394-400. doi: 10.1016/j.amjcard.2013.12.045. Epub 2014 Jan 31.
8
Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy.肥厚型心肌病中心房颤动的临床特征及预后意义
Cardiology. 2013;126(4):258-64. doi: 10.1159/000354953. Epub 2013 Oct 23.
9
Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review.肥厚型心肌病患者的心房颤动和血栓栓塞:系统评价。
Heart. 2014 Mar;100(6):465-72. doi: 10.1136/heartjnl-2013-304276. Epub 2013 Sep 7.
10
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断和治疗指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告。与美国胸外科协会、美国超声心动图学会、美国核心脏病学会、美国心力衰竭学会、心律学会、心血管造影和介入学会以及胸外科医师学会合作制定。
J Am Coll Cardiol. 2011 Dec 13;58(25):e212-60. doi: 10.1016/j.jacc.2011.06.011. Epub 2011 Nov 8.